Drug Type Antibody drug conjugate (ADC) |
Synonyms- |
Target |
Action antagonists, inhibitors |
Mechanism CXCR4 antagonists(C-X-C motif chemokine receptor 4 antagonists), LCK inhibitors(Tyrosine-protein kinase LCK inhibitors) |
Therapeutic Areas- |
Active Indication- |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC7H13NO3S |
InChIKeyGDDITXNHVSEICM-YFKPBYRVSA-N |
CAS Registry- |







